This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Increases Siemens’ industrial software total addressable market by $11 billion; aligns with strategic goal to accelerate customer innovation across industries
Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Amgen India investment totals $200 million through 2025
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Subscribe To Our Newsletter & Stay Updated
